Evidence map›Paper›PMID 36038349›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2022

[Sorafenib regulates vascular endothelial growth factor by runt-related transcription factor-3 to inhibit angiogenesis in hepatocellular carcinoma].

M Y Chai, B X Kou, Z Fu, F L Wei, S S Dou, D X Chen, X N Liu

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. [Factors affecting tumorigenicity in liver cancer xenografts].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

M Y ChaiBeijing You'an Hospital,Capital Medical University, Beijing 100069, China Beijing Institute of Hepatology, Beijing 100069, China.
B X KouBeijing You'an Hospital,Capital Medical University, Beijing 100069, China Beijing Institute of Hepatology, Beijing 100069, China.
Z FuBeijing You'an Hospital,Capital Medical University, Beijing 100069, China.
F L WeiBeijing You'an Hospital,Capital Medical University, Beijing 100069, China Beijing Institute of Hepatology, Beijing 100069, China.
S S DouBeijing You'an Hospital,Capital Medical University, Beijing 100069, China Beijing Institute of Hepatology, Beijing 100069, China.
D X ChenBeijing You'an Hospital,Capital Medical University, Beijing 100069, China Beijing Institute of Hepatology, Beijing 100069, China.
X N LiuBeijing You'an Hospital,Capital Medical University, Beijing 100069, China Beijing Institute of Hepatology, Beijing 100069, China.
Beijing YouAn Hospital · CN

Funding

Beijing Municipal Institute of Public Medical Research Development and Reform Pilot Project Jingyiyan-2019-6Beijing Municipal Natural Science Foundation 7192084National Science and Technology Major Project of China 2018ZX10302-205-005-001the Capital Health Research and Development of Special 2020-2-1152
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic AgentsCarcinoma, HepatocellularLiver NeoplasmsCell Line, TumorCore Binding Factor Alpha 3 SubunitHumansNeovascularization, PathologicNiacinamidePhenylurea CompoundsSorafenibVascular Endothelial Growth Factor AAntineoplastic AgentsCore Binding Factor Alpha 3 SubunitNiacinamidePhenylurea CompoundsSorafenibVascular Endothelial Growth Factor A

Identifiers

PMID36038349
PMCPMC12770745
OpenAlexW4293677684

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.